HB 380 requires Utah hospitals to establish systems for tracking and reporting workplace violence incidents involving staff. Hospitals must record details like incident timing, victim job roles, perpetrator type (patient, visitor, or employee), and responses; prohibit retaliation against reporters; and submit quarterly data to medical/nursing leadership by November 2026. They must also maintain records for two years and provide annual reports to the state department. The bill also delays repealing enhanced criminal penalties for violence against health facility employees until 2032.
HB 205 creates new pathways for substance use treatment within Utah's criminal justice system. It allows county jails to establish recovery housing pods for incarcerated individuals with substance use disorders, requiring approval by local substance abuse authorities and structured treatment programs. The bill also restricts syringe exchange programs to only distributing syringes (not other drug paraphernalia) and prohibits exchanges in public parks. Additionally, it authorizes courts to implement structured treatment programs for drug offenses and issue geographic "off-limits" orders for individuals charged with drug crimes. These changes primarily affect jails, local health authorities, and courts managing drug-related cases.
HB 402 creates a new state license specifically for emergency medical services (EMS) agencies to legally handle controlled substances (like naloxone or epinephrine) during emergencies. It requires EMS agencies to obtain this license, mandates record-keeping and storage rules, and authorizes the Division of Professional Licensing to enforce standards, deny/suspend licenses for violations, and collect fees. The bill directly affects all Utah EMS agencies currently distributing controlled substances, ensuring they operate under unified state regulations instead of relying solely on federal rules. Key provisions include requiring medical directors to issue standing orders for substance administration and setting clear procedures for license management and inspections.
SB 222 amends Utah's "Right to Try" law to expand access to investigational drugs. It removes the requirement that patients have a terminal illness, instead allowing individuals with serious conditions that pose significant risks compared to experimental treatments and limited conventional options to qualify. The bill updates definitions to clarify "eligible illness" and expands permissible medicinal dosage forms (e.g., adding transdermal and sublingual options). This change directly affects patients seeking experimental treatments who previously faced eligibility barriers due to non-terminal diagnoses. The law takes effect May 6, 2026, with no new funding required.
SB 170 requires healthcare providers and unlicensed midwives to administer vitamin K to newborn infants within 24 hours of birth. Parents may decline this administration by signing a form acknowledging the risks of not receiving vitamin K, which must be included in the infant's medical record. The bill defines key terms like "health care provider" and "unlicensed direct-entry midwife" and applies to all newborns in Utah. This directly affects newborns, their caregivers, and healthcare providers during delivery.
SB 204 requires Utah health insurers to apply the same cost-sharing rules (like copays and deductibles) for physical therapy services as they do for primary care visits. This directly affects patients seeking physical therapy and insurers, ensuring they pay no more out-of-pocket for PT than for a primary care visit. The bill amends Utah law to prohibit insurers from charging higher fees or imposing extra costs for physical therapy compared to primary care, while clarifying that physical therapists must still practice within existing scope-of-practice laws. It takes effect January 1, 2027, with no new funding required.
HB 15 amends Utah's Medicaid expansion program to address potential reductions in federal funding. It changes the automatic end date for the expansion if federal matching funds decrease, requires the Department of Health and Human Services to terminate programs that would reduce federal funds, and mandates a report to the legislature if funding drops. The bill also allows the state tax funding Medicaid expansion to end if the program concludes. These changes directly affect Utah's Medicaid beneficiaries and the state's administration of the program, focusing on maintaining federal funding alignment without new state spending.
HB 258 requires health insurance plans in Utah to cover reversal treatments for gender transition if the plan covers transition-related care. Specifically, plans covering hormonal transgender treatments must also cover reversal hormonal treatments, and plans covering surgical sex transition procedures must cover reversal surgeries. This applies to all health benefit plans renewed or entered into on or after January 1, 2027. The bill directly affects insurers and policyholders by mandating this coverage, without appropriating funds or adding new administrative requirements.
HB 264 modifies Utah's prescription medication rules to streamline pharmacy operations. It removes the requirement for pharmacies to notify providers when substituting medications (as authorized by the prescription), allows prescription refills to remain valid for two years, and establishes new rules for standing prescriptions issued by the Department of Health and Human Services. Standing prescriptions must be limited to specific conditions, FDA-approved diagnoses, and clinically appropriate treatments. These changes primarily affect pharmacies, patients receiving refills, and healthcare providers who write prescriptions.
SB 87 allows healthcare providers and overdose outreach groups to legally administer or dispense **expired naloxone** (up to 24 months past expiration) without fear of legal liability, as long as it’s done in good faith during an overdose emergency. It specifically extends immunity from civil lawsuits or criminal charges for using expired naloxone, clarifies that prescribing/dispensing expired naloxone isn’t unprofessional conduct, and requires providers to educate recipients on its safety, efficacy, and risks. The bill directly affects **licensed healthcare professionals, overdose outreach programs, and individuals at high risk of opioid overdose** (or their family/friends who may assist them). Key provisions include permitting expired naloxone use under standing prescriptions and ensuring providers give clear instructions on overdose response. The law does not change existing rules for non-expired naloxone.
